⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Foundayo™ (orforglipron), Lilly's new oral GLP-1 pill for weight loss, now available in the U.S.
prnewswire.com
LLY
Novi Weight Loss GLP-1 Program (2026): What 50,000 People Searching This Brand Need to Know Before Enrolling
accessnewswire.com
NVO
LLY
Nxera Pharma Achieves Second Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases
globenewswire.com
LLY
FedEx, USAA, and Home Depot Lead Newsweek’s America’s Greatest Workplaces for Mental Well-Being 2026
globenewswire.com
FDX
HD
ABT
JNJ
MSFT
INTC
LLY
DAL
Incyclix Bio Raises Additional $5 Million in Series B Financing to Advance Clinical Trial of INX-315 in Patients with CDK4/6 Inhibitor Resistant ER+/HER2- Breast Cancer or CCNE1-Amplified Solid Tumors
globenewswire.com
LLY
Buchanan Capital Partners and The Hanover Company Close Joint Venture for North Airport Logistics Center
prnewswire.com
LLY
FOX
Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval
accessnewswire.com
LEXX
LLY
19th Annual Morgan & Morgan Walk for Wishes® Raises Over $583,000 to Grant Life-Changing Wishes
globenewswire.com
GOOG
META
LLY
Joi + Blokes Compounded GLP-1 Review 2026: Semaglutide, Tirzepatide, Pricing, and Everything to Verify Before You Enroll
accessnewswire.com
NVO
LLY
RO LAUNCHES ELI LILLY'S KWIKPEN®, OFFERING PATIENTS A MORE CONVENIENT WAY TO TAKE ZEPBOUND®
prnewswire.com
LLY